Filing Details

Accession Number:
0001181431-11-011863
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-22 16:18:05
Reporting Period:
2011-02-17
Filing Date:
2011-02-22
Accepted Time:
2011-02-22 16:18:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1234564 W Brian Metcalf Experimental Station
Route 141 &Amp; Henry Clay Road
Wilmington DE 19880
Chief Drug Discovery Scientist No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-17 50,000 $5.97 116,504 No 4 M Direct
Common Stock Disposition 2011-02-17 50,000 $14.35 66,504 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options Disposition 2011-02-17 50,000 $0.00 50,000 $5.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-11-06 No 4 M Direct
Footnotes
  1. Beginning November 7, 2002, options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remainder vesting monthly over three years.